glp 1 drugs and blindness Ozempic & GLP-1s Linked to NAION, & Vision Loss? Lawsuits claiming Ozempic, other GLP-1s

Marso et al., 2016)

Please confirm any data provided with the related suppliers or authors

Insulin resistance in polycystic ovarian syndrome

CRP (C-reactive protein) serves as the most commonly measured marker of systemic inflammation

46 Adverse Effects and Tolerability of GLP-1RAs in Clinical Practice Although the cardiovascular benefits of GLP-1RAs are significant, their use is commonly associated with well-characterised adverse effects that can affect tolerability and long-term medication adherence, as detailed below

Notably, gross spending does not account for drug rebates, which are paid by drug manufacturers to states and are shared between the states and the federal government to offset the overall cost of prescription drugs under states Medicaid programs